Skip to main content
PMC home page
Transactions of the American Clinical and Climatological Association logoLink to Transactions of the American Clinical and Climatological Association
. 1989;100:171–176.

Effects of experimental recombinant interferons on multiple sclerosis.

K P Johnson 1, H S Panitch 1
PMCID: PMC2376453  PMID: 2479162

Full text

PDF
171

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Camenga D. L., Johnson K. P., Alter M., Engelhardt C. D., Fishman P. S., Greenstein J. I., Haley A. S., Hirsch R. L., Kleiner J. E., Kofie V. Y. Systemic recombinant alpha-2 interferon therapy in relapsing multiple sclerosis. Arch Neurol. 1986 Dec;43(12):1239–1246. doi: 10.1001/archneur.1986.00520120023011. [DOI] [PubMed] [Google Scholar]
  2. Johnson K. P., Nelson B. J. Multiple sclerosis: diagnostic usefulness of cerebrospinal fluid. Ann Neurol. 1977 Nov;2(5):425–431. doi: 10.1002/ana.410020515. [DOI] [PubMed] [Google Scholar]
  3. Johnson K. P. Systemic interferon therapy for multiple sclerosis. Design of a trial. Arch Neurol. 1983 Oct 21;40(11):681–682. doi: 10.1001/archneur.1983.04050100021007. [DOI] [PubMed] [Google Scholar]
  4. Knobler R. L., Panitch H. S., Braheny S. L., Sipe J. C., Rice G. P., Huddlestone J. R., Francis G. S., Hooper C. K., Kamin-Lewis R. M., Johnson K. P. Systemic alpha-interferon therapy of multiple sclerosis. Neurology. 1984 Oct;34(10):1273–1279. doi: 10.1212/wnl.34.10.1273. [DOI] [PubMed] [Google Scholar]
  5. Kurtzke J. F., Gudmundsson K. R., Bergmann S. Multiple sclerosis in Iceland: 1. Evidence of a postwar epidemic. Neurology. 1982 Feb;32(2):143–150. doi: 10.1212/wnl.32.2.143. [DOI] [PubMed] [Google Scholar]
  6. Neighbour P. A., Bloom B. R. Absence of virus-induced lymphocyte suppression and interferon production in multiple sclerosis. Proc Natl Acad Sci U S A. 1979 Jan;76(1):476–480. doi: 10.1073/pnas.76.1.476. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Panitch H. S., Hirsch R. L., Schindler J., Johnson K. P. Treatment of multiple sclerosis with gamma interferon: exacerbations associated with activation of the immune system. Neurology. 1987 Jul;37(7):1097–1102. doi: 10.1212/wnl.37.7.1097. [DOI] [PubMed] [Google Scholar]
  8. Sibley W. A., Bamford C. R., Clark K. Clinical viral infections and multiple sclerosis. Lancet. 1985 Jun 8;1(8441):1313–1315. doi: 10.1016/S0140-6736(85)92801-6. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Transactions of the American Clinical and Climatological Association are provided here courtesy of American Clinical and Climatological Association

RESOURCES